<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Renerve Limited — News on 6ix</title>
    <link>https://6ix.com/company/renerve-limited</link>
    <description>Latest news and press releases for Renerve Limited on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 30 Apr 2026 04:11:06 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/renerve-limited" rel="self" type="application/rss+xml" />
    <item>
      <title>Q3 FY26 Activities Report and Appendix 4C</title>
      <link>https://6ix.com/company/renerve-limited/news/q3-fy26-activities-report-and-appendix-4c</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/q3-fy26-activities-report-and-appendix-4c</guid>
      <pubDate>Thu, 30 Apr 2026 04:11:06 GMT</pubDate>
      <description>Q3 FY26 Activities Report and Appendix 4C</description>
    </item>
    <item>
      <title>Nerve Guide Matrix Enters Stage 3 of Commercial Development</title>
      <link>https://6ix.com/company/renerve-limited/news/nerve-guide-matrix-enters-stage-3-of-commercial-development</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/nerve-guide-matrix-enters-stage-3-of-commercial-development</guid>
      <pubDate>Wed, 15 Apr 2026 04:06:04 GMT</pubDate>
      <description>Nerve Guide Matrix Enters Stage 3 of Commercial Development</description>
    </item>
    <item>
      <title>1HFY26 Results Announcement</title>
      <link>https://6ix.com/company/renerve-limited/news/1hfy26-results-announcement-5</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/1hfy26-results-announcement-5</guid>
      <pubDate>Thu, 26 Feb 2026 05:10:09 GMT</pubDate>
      <description>1HFY26 Results Announcement</description>
    </item>
    <item>
      <title>1HFY26 Appendix 4D and Half Year Report</title>
      <link>https://6ix.com/company/renerve-limited/news/1hfy26-appendix-4d-and-half-year-report-4</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/1hfy26-appendix-4d-and-half-year-report-4</guid>
      <pubDate>Thu, 26 Feb 2026 05:09:11 GMT</pubDate>
      <description>1HFY26 Appendix 4D and Half Year Report</description>
    </item>
    <item>
      <title>Q2 FY26 Activities Report and Appendix 4C</title>
      <link>https://6ix.com/company/renerve-limited/news/q2-fy26-activities-report-and-appendix-4c</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/q2-fy26-activities-report-and-appendix-4c</guid>
      <pubDate>Fri, 30 Jan 2026 04:48:13 GMT</pubDate>
      <description>Q2 FY26 Activities Report and Appendix 4C</description>
    </item>
    <item>
      <title>ReNerve receives approval in Malaysia</title>
      <link>https://6ix.com/company/renerve-limited/news/renerve-receives-approval-in-malaysia</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/renerve-receives-approval-in-malaysia</guid>
      <pubDate>Thu, 15 Jan 2026 03:38:15 GMT</pubDate>
      <description>ReNerve receives approval in Malaysia</description>
    </item>
    <item>
      <title>Broader approval received in Hong Kong for Nerve Cuff</title>
      <link>https://6ix.com/company/renerve-limited/news/broader-approval-received-in-hong-kong-for-nerve-cuff</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/broader-approval-received-in-hong-kong-for-nerve-cuff</guid>
      <pubDate>Mon, 12 Jan 2026 03:41:07 GMT</pubDate>
      <description>Broader approval received in Hong Kong for Nerve Cuff</description>
    </item>
    <item>
      <title>ReNerve AGM Presentation</title>
      <link>https://6ix.com/company/renerve-limited/news/renerve-agm-presentation</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/renerve-agm-presentation</guid>
      <pubDate>Thu, 27 Nov 2025 03:57:07 GMT</pubDate>
      <description>ReNerve AGM Presentation</description>
    </item>
    <item>
      <title>ReNerve completes $3.2m capital raising</title>
      <link>https://6ix.com/company/renerve-limited/news/renerve-completes-dollar32m-capital-raising</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/renerve-completes-dollar32m-capital-raising</guid>
      <pubDate>Thu, 20 Nov 2025 04:07:07 GMT</pubDate>
      <description>ReNerve completes $3.2m capital raising</description>
    </item>
    <item>
      <title>Trading Halt</title>
      <link>https://6ix.com/company/renerve-limited/news/trading-halt-1289</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/trading-halt-1289</guid>
      <pubDate>Tue, 18 Nov 2025 03:26:06 GMT</pubDate>
      <description>Trading Halt</description>
    </item>
    <item>
      <title>Nerve Cuff approved for use in US DoD and VA hospitals</title>
      <link>https://6ix.com/company/renerve-limited/news/nerve-cuff-approved-for-use-in-us-dod-and-va-hospitals</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/nerve-cuff-approved-for-use-in-us-dod-and-va-hospitals</guid>
      <pubDate>Thu, 13 Nov 2025 03:53:18 GMT</pubDate>
      <description>Nerve Cuff approved for use in US DoD and VA hospitals</description>
    </item>
    <item>
      <title>ReNerve Clinical Study Expansion</title>
      <link>https://6ix.com/company/renerve-limited/news/renerve-clinical-study-expansion</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/renerve-clinical-study-expansion</guid>
      <pubDate>Wed, 05 Nov 2025 04:03:13 GMT</pubDate>
      <description>ReNerve Clinical Study Expansion</description>
    </item>
    <item>
      <title>Q1 FY26 Activities Report and Appendix 4C</title>
      <link>https://6ix.com/company/renerve-limited/news/q1-fy26-activities-report-and-appendix-4c</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/q1-fy26-activities-report-and-appendix-4c</guid>
      <pubDate>Thu, 23 Oct 2025 02:07:11 GMT</pubDate>
      <description>Q1 FY26 Activities Report and Appendix 4C</description>
    </item>
    <item>
      <title>ReNerve achieves first sales of amniotic tissue range</title>
      <link>https://6ix.com/company/renerve-limited/news/renerve-achieves-first-sales-of-amniotic-tissue-range</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/renerve-achieves-first-sales-of-amniotic-tissue-range</guid>
      <pubDate>Tue, 14 Oct 2025 02:27:07 GMT</pubDate>
      <description>ReNerve achieves first sales of amniotic tissue range</description>
    </item>
    <item>
      <title>Investor Roadshow Presentation</title>
      <link>https://6ix.com/company/renerve-limited/news/investor-roadshow-presentation-5</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/investor-roadshow-presentation-5</guid>
      <pubDate>Mon, 29 Sep 2025 03:50:10 GMT</pubDate>
      <description>Investor Roadshow Presentation</description>
    </item>
    <item>
      <title>Empliq Product Launch</title>
      <link>https://6ix.com/company/renerve-limited/news/empliq-product-launch</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/empliq-product-launch</guid>
      <pubDate>Mon, 22 Sep 2025 04:05:14 GMT</pubDate>
      <description>Empliq Product Launch</description>
    </item>
    <item>
      <title>ReNerve launches the EmpliQ product ranges</title>
      <link>https://6ix.com/company/renerve-limited/news/renerve-launches-the-empliq-product-ranges</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/renerve-launches-the-empliq-product-ranges</guid>
      <pubDate>Mon, 22 Sep 2025 04:04:15 GMT</pubDate>
      <description>ReNerve launches the EmpliQ product ranges</description>
    </item>
    <item>
      <title>ReNerve - Appendix 4E</title>
      <link>https://6ix.com/company/renerve-limited/news/renerve-appendix-4e</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/renerve-appendix-4e</guid>
      <pubDate>Fri, 29 Aug 2025 03:39:40 GMT</pubDate>
      <description>ReNerve - Appendix 4E</description>
    </item>
    <item>
      <title>ReNerve records first sale of deep dermal product range</title>
      <link>https://6ix.com/company/renerve-limited/news/renerve-records-first-sale-of-deep-dermal-product-range</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/renerve-records-first-sale-of-deep-dermal-product-range</guid>
      <pubDate>Mon, 18 Aug 2025 03:59:22 GMT</pubDate>
      <description>ReNerve records first sale of deep dermal product range</description>
    </item>
    <item>
      <title>Q4 FY25 Activities Report and Appendix 4C</title>
      <link>https://6ix.com/company/renerve-limited/news/q4-fy25-activities-report-and-appendix-4c</link>
      <guid isPermaLink="true">https://6ix.com/company/renerve-limited/news/q4-fy25-activities-report-and-appendix-4c</guid>
      <pubDate>Wed, 30 Jul 2025 04:24:14 GMT</pubDate>
      <description>Q4 FY25 Activities Report and Appendix 4C</description>
    </item>
  </channel>
</rss>